Vaxcyte, Inc. (1PCVX)
MTA
Real-time Data
07:00 AM
Day's Range
53.5052 wk Range
24.20Overview - 1PCVX - Vaxcyte, Inc.
Key Statistics
Valuation
Enterprise Value
5.77B
P/E (Trailing)
‪-9.41‬
PEG Ratio
‪-0.15‬
Price / Book
‪3.37‬
EV / EBITDA
‪-5.86‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-22.60%‬
Return on Equity
‪-36.51%‬
Ownership
Shares Outstanding
144.78M
Float
136.17M
Held by Insiders
‪0.48%‬
Held by Institutions
‪113.44%‬
Price stats
Beta
‪1.21‬
50-Day Avg
‪48.27‬
200-Day Avg
‪45.43‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - 1PCVX - Vaxcyte, Inc.
Peers - 1PCVX - Vaxcyte, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
- 1PCVXMTAVaxcyte, Inc.5.41BMarket Cap+54.77%52-week change-9.50P/E (Trailing)‪0.00%‬Profit Margin
- 1VRTXMTAVertex Pharmaceuticals Incorporated107.27BMarket Cap+27.82%52-week change32.13P/E (Trailing)‪34.99%‬Profit Margin
- 1REGNMTARegeneron Pharmaceuticals Inc.73.52BMarket Cap+28.94%52-week change20.61P/E (Trailing)‪27.86%‬Profit Margin
- 1ALNYMTAAlnylam Pharmaceuticals Inc45.81BMarket Cap-89.61%52-week change41.96P/E (Trailing)‪16.12%‬Profit Margin
- 1ALABMTAASTERA LABS INC COMMON STOCK (Ticker: 1ALAB)41.80BMarket Cap+47.15%52-week change137.71P/E (Trailing)‪30.74%‬Profit Margin
- 1INSMMTAInsmed Inc30.28BMarket Cap+16.20%52-week change-17.19P/E (Trailing)‪-76.94%‬Profit Margin
- 1CGMTAThe Carlyle Group Inc.18.64BMarket Cap-16.74%52-week change50.83P/E (Trailing)‪13.01%‬Profit Margin
Profile Summary - 1PCVX - Vaxcyte, Inc.
About
Vaxcyte, Inc. is a clinical-stage biotechnology company specializing in the development of next-generation vaccines to combat bacterial infectious diseases. Its pipeline is centered on innovative conjugate and novel protein vaccines, with key candidates such as VAX-24, a 24-valent pneumococcal conjugate vaccine for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
